Table 2.
Items | Dead | Surviving | HR | HR (95% CI) | P |
---|---|---|---|---|---|
Sex | |||||
Male | 8 | 5 | 1.923 | 0.611–6.057 | 0.264 |
Female | 5 | 16 | |||
Age group | |||||
≤60 years old | 7 | 19 | 3.566 | 1.142–11.135 | 0.029 |
>60 years old | 6 | 2 | |||
Tumor size | |||||
≤7.5 cm | 4 | 12 | 5.752 | 0.447–23.107 | 0.104 |
>7.5 cm | 9 | 9 | |||
ALT level | |||||
≤98.5 μmol/L | 3 | 3 | 0.374 | 0.048–2.890 | 0.346 |
>98.5 μmol/L | 10 | 18 | |||
TBIL level | |||||
≤23.5 μmol/L | 10 | 15 | 0.484 | 0.124–1.885 | 0.296 |
>23.5 μmol/L | 3 | 6 | |||
Mural nodules | |||||
Yes | 12 | 17 | 1.425 | 0.179–11.321 | 0.738 |
No | 1 | 4 | |||
Surgical type | |||||
Radical resection | 8 | 19 | 0.155 | 0.067–0.863 | 0.007 |
Palliative surgery | 5 | 1 | |||
Lymphatic invasion | |||||
Yes | 2 | 1 | 5.209 | 1.029–26.370 | 0.046 |
No | |||||
Mesenchymal stroma | |||||
Yes | 6 | 12 | 0.776 | 0.246–2.444 | 0.665 |
No | 7 | 9 | |||
Tumor growth type | |||||
Invasive type | 7 | 6 | 0.266 | 0.076–0.930 | 0.038 |
Noninvasive type | 6 | 15 |
CI: Confidence interval; ALT: Alanine aminotransferase; TBIL: Total bilirubin; HR: Hazard ratio.